Alopecia areata - Alopeetsia Areata
☆ Saksamaa 2022. aasta Stiftung Warentesti tulemustes oli tarbijate rahulolu ModelDermiga vaid veidi madalam kui tasuliste telemeditsiini konsultatsioonidega.
Alopeetsia Areata (Alopecia areata) on näha peanaha tagaküljel. Tüüpilistel juhtudel ilmub see ootamatult täiesti sileda pinnaga ja suurusega 2-3 cm.
References
Alopecia areata on seisund, kus teie immuunsüsteem ründab teie juuksefolliikulisid, põhjustades ajutist juuste väljalangemist ilma armistumiseta. See võib ilmneda juuste väljalangemise laikudena või mõjutada kogu teie peanahka või keha, mõjutades mingil eluetapil umbes 2% inimestest. Peamine süüdlane näib olevat juuksefolliikulite ümbritseva loomuliku kaitse katkemine.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata on seisund, kus immuunsüsteem ründab juuksefolliikulisid, põhjustades juuste väljalangemist peanahal ja muudel karvastel kehaosadel. See mõjutab umbes 2% inimestest kogu maailmas. Kuigi see võib ilmneda igas vanuses, on see lastel tavalisem kui täiskasvanutel (1. 92% vs. 1. 47%) . Naised, eriti üle 50-aastased, kogevad seda sagedamini kui mehed. Kortikosteroidide süstimine otse kahjustatud piirkondadesse on andnud paremaid tulemusi kui nende paikne manustamine.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Arvatakse, et alopeetsia areata on autoimmuunhaigus, mis on seotud juuksefolliikulite immuunsüsteemiga. Selle aluseks olev mehhanism seisneb selles, et keha ei suuda oma rakke ära tunda, millele järgneb karvanääpsu immuunvahendatud hävimine.
○ Ravi ― OTC ravimid
Mõned kerge alopeetsia areataga inimesed paranevad aasta jooksul ilma ravita. Kuid enamikul inimestel esineb peanaha juhuslikes kohtades kordusi.
#Hydrocortisone cream
○ Ravi
Intralesionaalsed steroidide süstid on kõige tõhusam ravi. Immunoteraapiat võib proovida, kui kahjustatud on suured peanaha piirkonnad.
#Triamcinolone intralesional injection
#DPCP immunotherapy